06,02,2026 118 views
On October 16-17, 2023, commissioned by the State Administration for Market Regulation (CMA), the National CMA Evaluation Expert Group conducted an on-site evaluation of the China Micro Testing Laboratory and successfully passed it.
This review is for our company's Medical Device Inspection and Testing Agency Qualification Certification (CMA). During the review period, the expert group conducts evaluations through on-site observation, listening to reports, reviewing materials, conducting on-site experiments, and assessing authorized signatories. They review the compliance of laboratory quality management system documents, the effectiveness of system operation, as well as the abilities of laboratory personnel, facility environment, instruments and equipment, and on-site experiments.
After review, the experts of the review team unanimously agreed that Huawei Testing has established a standardized and complete quality management system in accordance with relevant regulatory requirements. All quality activities are under control, and the laboratory hardware facilities, management level, and testing capabilities meet the requirements. The review team unanimously agreed to recommend the technical capabilities and authorized signatories of the application.
The successful passing of the on-site evaluation of Huawei Testing marks a new level of management and testing capabilities for Huawei. Huawei will take this opportunity to continuously strengthen its management system construction, steadily improve its capacity building level, and provide more solid and powerful technical support for promoting high-quality development both inside and outside the region, contributing to the strength of Huawei.
The company's business scope covers fields such as biomedicine, medical devices, and health products, and is committed to providing one-stop testing and analysis services for enterprises, research and development institutions in the fields of biosafety, biomedicine, and big health.
